Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors

ERBB2 abnormalities frequently occur and serve as rationale therapeutic targets in cancer. In this study, clinical and next-generation sequencing data from 14,956 patients across more than 20 tumor types were collected. A total of 406 (2.7%) patients were identified with ERBB2 amplifications, and 30...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hao, Miao, Ji, Wen, Yazhou, Xia, Xihua, Chen, Yanan, Huang, Mengli, Chen, Shiqing, Zhao, Zhengyi, Zhang, Yuzi, Chen, Chunzhu, Zhu, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325965/
https://www.ncbi.nlm.nih.gov/pubmed/35911441
http://dx.doi.org/10.3389/pore.2022.1610360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325965/
https://www.ncbi.nlm.nih.gov/pubmed/35911441
http://dx.doi.org/10.3389/pore.2022.1610360

Ejemplares similares